期刊文献+

Sequential defunctionalization followed by thyroxine supple-mentation as preoperative preparation of hyperthyroid patients undergoing thyroidectomy 被引量:2

Sequential defunctionalization followed by thyroxine supple-mentation as preoperative preparation of hyperthyroid patients undergoing thyroidectomy
原文传递
导出
摘要 Background Preparing hyperthyroid patients for thyroid surgery with a combination of antithyroid drugs and thyroxine has long been controversial because this combination usually results in only partial inhibition of thyroid function. We therefore used large doses of antithyroid drugs to completely inhibit the synthesis of thyroxine and render the thyroid gland defunctionalized. We then administered physiologic doses of thyroxine to inhibit thyroid-stimulating hormone secretion. We have named this treatment “sequential thyroid defunctionalization followed by thyroxine supplementation.” Methods Four hundred and seventy-one hyperthyroid patients seen at our hospital were divided into experimental and control groups. The control group was treated preoperatively with antithyroid drugs and iodine preparation. The experimental group was further divided into four subgroups and treated with “sequential thyroid defunctionalization followed by thyroxine supplementation”. Each of the four subgroups received different doses of antithyroid drugs and thyroxine for differing time periods. Thyroid function was assessed at each stage of treatment, as were operative blood loss volumes and postoperative complications. Results Compared to the control group, the four experimental groups showed less thyroid congestion and surface varices at surgery. Patients in subgroup A also had thyroid glands that were almost histologically normal. The mean operative blood loss volume of the experimental group was less than that of the control group ((326±163) ml in the control group; (196±57) ml in subgroup A; (230±71) ml in subgroup B; (240±80) ml in subgroup C; and (312±97) ml in subgroup D). The postoperative complication rate of the experimental group was 8.64% (21/243) whereas that of the control group was 17.54% (40/228). Conclusions Sequential thyroid defunctionalization followed by thyroxine supplementation is effective in reducing the bleeding volume and postoperative complication rate in selected hyperthyroid patients undergoing thyroidectomy. Background Preparing hyperthyroid patients for thyroid surgery with a combination of antithyroid drugs and thyroxine has long been controversial because this combination usually results in only partial inhibition of thyroid function. We therefore used large doses of antithyroid drugs to completely inhibit the synthesis of thyroxine and render the thyroid gland defunctionalized. We then administered physiologic doses of thyroxine to inhibit thyroid-stimulating hormone secretion. We have named this treatment “sequential thyroid defunctionalization followed by thyroxine supplementation.” Methods Four hundred and seventy-one hyperthyroid patients seen at our hospital were divided into experimental and control groups. The control group was treated preoperatively with antithyroid drugs and iodine preparation. The experimental group was further divided into four subgroups and treated with “sequential thyroid defunctionalization followed by thyroxine supplementation”. Each of the four subgroups received different doses of antithyroid drugs and thyroxine for differing time periods. Thyroid function was assessed at each stage of treatment, as were operative blood loss volumes and postoperative complications. Results Compared to the control group, the four experimental groups showed less thyroid congestion and surface varices at surgery. Patients in subgroup A also had thyroid glands that were almost histologically normal. The mean operative blood loss volume of the experimental group was less than that of the control group ((326±163) ml in the control group; (196±57) ml in subgroup A; (230±71) ml in subgroup B; (240±80) ml in subgroup C; and (312±97) ml in subgroup D). The postoperative complication rate of the experimental group was 8.64% (21/243) whereas that of the control group was 17.54% (40/228). Conclusions Sequential thyroid defunctionalization followed by thyroxine supplementation is effective in reducing the bleeding volume and postoperative complication rate in selected hyperthyroid patients undergoing thyroidectomy.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2008年第20期2010-2015,共6页 中华医学杂志(英文版)
关键词 HYPERTHYROIDISM preoperative procedures THYROXINE hyperthyroidism preoperative procedures thyroxine
  • 相关文献

同被引文献29

  • 1李新春,汪卫勇.碘剂、心得安配合糖皮质激素对甲亢术后的影响[J].湖北中医杂志,2007,29(8):24-24. 被引量:1
  • 2肖艳梅.甲状腺功能亢进性心脏病的临床诊断与防治[J].实用心脑肺血管病杂志,2013,21(7):158.
  • 3Fazio S,Palmieri E A,Lombardi G,et al.Effects of thyroid hormone on the cardiovascular system[J].Recent Progress in Hormone Research,2004,59(1):31-50.
  • 4Andrade VA,Gross JL,Maia AL.The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves'hyperthyroidism:one-year follow-up of a prospective,randomized study[J].The Journal of Clinical Endocrinology&Metabolism,2001,86(8):3488-3493.
  • 5Miyauchi S,Matsuura B,Onji M.Increased Levels of Serum lnterleukin-18 in Graves'Disease[J].Thyroid,2000,10(9):815-819.
  • 6Aniszewski JP,Valyasevi RW,Bahn RS.Relationship between disease duration and predominant orbital T cell subset in Graves'ophthalmopathy[J].The Journal of Clinical Endocrinology&Metabolism,2000,85(2):776-780.
  • 7Okumura M,Hidakay OH,Matsuzuka F,et al.CD30expression and interleukin-4 and interferon-y production of intrathyroidal lymphocytes in Graves'disease[J].Thyroid,1999,9(4):333-339.
  • 8Bschor T,Baethge C,Adli M,et al.Hypothalamic-pituitarythyroid system activity during lithium augmentation therapy in patients with unipolar major depression[J].Journal of Psychiatry and Neuroscience,2003,28(3):210.
  • 9Strigari L,Sciuto R,Benassi M,et al.A NTCP approach for estimating the outcome in radioiodine treatment of hyperthyroidism[J].Medical physics,2008,35(9):3903-3910.
  • 10Hurley JR.Orbitopathy after treatment of Graves'disease[J].Journal of Nuclear Medicine,1994,35(5):918-920.

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部